Who
Jonathan Rigby
Director
Company insider
Files Form 4 as: Director, Oncolytics Biotech; Director, Xeris Pharmaceuticals; President and CEO, SteadyMed; VP, Business Development, Aradigm.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $1.1M
- Companies
- 4
- Companies where not an officer
- 2
- First trade
- 12 Apr 2006
- Last trade
- 1 Jun 2026
- Last filed
- 3 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jun 2026filed 3 Jun 2026 | ONCY Oncolytics Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 1 Jun 2026filed 3 Jun 2026 | ONCY Oncolytics Biotechoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 27 Feb 2019filed 1 Mar 2019 | Xeris Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 30 Aug 2018filed 4 Sep 2018 | SteadyMed | SEC FORM 4 Sold | $186K41,605 at $4.46 | filing |
| 30 Aug 2018filed 4 Sep 2018 | SteadyMed | SEC FORM 4 Sold | $22K4,960 at $4.46 | filing |
| 30 Aug 2018filed 4 Sep 2018 | SteadyMedoption or derivative | SEC FORM 4 Code J | —18,515 at $0.00 | filing |
| 30 Aug 2018filed 4 Sep 2018 | SteadyMedoption or derivative | SEC FORM 4 Code J | —145,212 at $0.00 | filing |
| 30 Aug 2018filed 4 Sep 2018 | SteadyMedoption or derivative | SEC FORM 4 Code J | —131,451 at $0.00 | filing |
| 30 Aug 2018filed 4 Sep 2018 | SteadyMedoption or derivative | SEC FORM 4 Code J | —63,764 at $0.00 | filing |
| 30 Aug 2018filed 4 Sep 2018 | SteadyMedoption or derivative | SEC FORM 4 Code J | —163,394 at $0.00 | filing |
| 24 Aug 2018filed 27 Aug 2018 | SteadyMedoption or derivative | SEC FORM 4 Code M | —16,994 at $0.00 | filing |
| 24 Aug 2018filed 27 Aug 2018 | SteadyMed | SEC FORM 4 Code M | $47K16,994 at $2.74 | filing |
| 24 Aug 2018filed 27 Aug 2018 | SteadyMed | SEC FORM 4 Sold | $80K16,994 at $4.70 | filing |
| 23 Aug 2018filed 27 Aug 2018 | SteadyMedoption or derivative | SEC FORM 4 Code M | —44,242 at $0.00 | filing |
| 23 Aug 2018filed 27 Aug 2018 | SteadyMed | SEC FORM 4 Code M | $121K44,242 at $2.74 | filing |
| 23 Aug 2018filed 27 Aug 2018 | SteadyMed | SEC FORM 4 Sold | $209K44,242 at $4.73 | filing |
| 17 Aug 2018filed 17 Aug 2018 | SteadyMed | SEC FORM 4 Sold | $414K88,831 at $4.66 | filing |
| 9 Aug 2018filed 10 Aug 2018 | SteadyMed | SEC FORM 4 Code M | $321K88,831 at $3.61 | filing |
| 9 Aug 2018filed 10 Aug 2018 | SteadyMedoption or derivative | SEC FORM 4 Code M | —88,831 at $0.00 | filing |
| 2 Jul 2018filed 3 Jul 2018 | SteadyMed | SEC FORM 4 Sold | $187K41,605 at $4.50 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.